[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Pages 8432-8433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02505]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Sole Source Cooperative Agreement To Fund 
Namibia Ministry of Health and Social Services (MOHSS), Rwanda 
Biomedical Center, South African Medical Research Council, South 
African National AIDS Council Trust (SANAC), Tanzania Commission for 
AIDS (TACAIDS), President's Office--Regional Administration and Local 
Government (PO-RALG), and Vietnam Administration for HIV/AIDS Control 
(VAAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award(s) of approximately $8,000,000 for Year 1 funding to MOHSS, 
$4,000,000 for Year 1 funding to Rwanda Biomedical Center, $3,000,000 
for Year 1 funding to South African Medical Research Council, 
$3,000,000 for Year 1 funding to SANAC, $500,000 for Year 1 funding to 
TACAIDS, $500,000 for Year 1 funding to PO-RALG, and $6,000,000 for 
Year 1 funding to VAAC. The(se) award(s) will strengthen comprehensive 
and integrated service delivery for prevention, implement strategies 
and activities that strengthen local entities, support the 
coordination, management, and monitoring of multi-sectoral 
implementation, foster the government's capacity to provide 
comprehensive management of the HIV program, and implement a 
sustainable and quality-assured HIV diagnostic, testing, and health 
information management program in Namibia, Rwanda, South Africa, 
Tanzania, and Vietnam. Funding amounts for years 2-5 will be set at 
continuation.

DATES: The period for these award will be September 30, 2024, through 
September 29, 2029.

FOR FURTHER INFORMATION CONTACT: Benjamin Monroe, Center for Global 
Health, Centers for Disease Control and Prevention, CDC Namibia, 
Private Bag 12029, Ausspannplatz, Windhoek, Namibia, Telephone: 
404.639.1523, Email: [email protected].
    Antyme Kayisabe, Center for Global Health, Centers for Disease 
Control and Prevention, US Embassy Kigali; 30KG 7 Avenue (Kacyiru); 
P.O. Box 28 Kigali, Rwanda, Telephone: 788.382.114, Email: 
[email protected].
    Rehmeth Fakroodeen, Center for Global Health, Centers for Disease 
Control and Prevention, 100 Totius Street, Groenkloof, Pretoria,0181, 
Telephone: 278.252.43786, Email: [email protected].
    Rachael Joseph, Center for Global Health, Centers for Disease 
Control and Prevention, 100 Totius Street, Groenkloof, Pretoria,0181, 
Telephone: 27 822544430, Email: [email protected].
    Angela Schaad, Center for Global Health, Centers for Disease 
Control and Prevention, 2448 Luthuli Road Dar Es Salaam Tanzania, 
Telephone: 404.718.3639, Email: [email protected].
    Amy Bailey, Center for Global Health, Centers for Disease Control 
and Prevention, 5th/Floor Tung Shing Building, No 2, Ngo Quyen Street, 
Hoan Kiem District Hanoi, Vietnam, Telephone: 011842439352692, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: The(se) sole source award(s) will maintain 
HIV and achieve TB epidemic control and strengthen public health 
systems and security, implement evidence-based decision-making, 
technical leadership, and coordination of quality HIV prevention and 
care and treatment (C&T) services, strengthen systems and processes at 
multiple health system levels, support coordination and implementation 
of United States Government (USG)-funded public health activities, and 
ensure the quality of HIV diagnostics and testing, track the quality of 
services to persons living with HIV (PLHIV) on treatment, and monitor 
the cascade progression to HIV epidemic control in Namibia, Rwanda, 
South Africa, Tanzania, and Vietnam.
    MOHSS is in a unique position to conduct this work, as it is the 
sole government entity charged with the operation of Namibia's public 
healthcare system. It is the only body authorized by law to develop and 
implement health policies in the public health sector, and to enforce 
national health laws in the public and private healthcare sectors. As 
the government ministry with exclusive authority over the healthcare 
system, it is the only organization in Namibia eligible to receive 
direct government-to-government support for the HIV/AIDS activities 
proposed by CDC.
    Rwanda Biomedical Center is in a unique position to conduct this 
work, as it develops policies and regulations for medical laboratories, 
conducts specialized testing, monitors the performance and operation of 
other

[[Page 8433]]

laboratories in Rwanda, and establishes relations and collaborations 
with other national and international agencies carrying out similar 
responsibilities. No other agency in the public or private sector 
performs this responsibility.
    South African Medical Research Council is in a unique position to 
conduct this work, as it is a government body responsible for 
biomedical research of national importance and is the only agency with 
this direct governmental mandate in South Africa.
    SANAC is in a unique position to conduct this work, as it is 
mandated to coordinate a truly multi-sectoral response to the epidemics 
at a national and sub-national level. Therefore, SANAC is authorized to 
collaborate with government departments, the private health sector, 
other development partners, and non-governmental organizations (NGOS) 
to develop strategies to reach epidemic control.
    TACAIDS is in a unique position to conduct this work, as it has 
sole legal authority to provide strategic multi-sectorial leadership 
and to coordinate and strengthen efforts of all stakeholders involved 
in the national HIV/AIDS response. TACAIDS has 16 functions to aid in 
achieving their mandate.
    PO-RALG is in a unique position to conduct this work, as it is 
legally the only government agency that interprets national policies, 
strategies, and guidelines related to health and social welfare sector 
development, financing, and human resources; provides supportive 
supervision and mentorship to RAs and LGAs; and ensures implementation 
of policies and regulations by RAs and LGAs. PO-RALG has oversight and 
management of all dispensaries, health facilities, and regional 
hospitals, as well as all health care workers.
    VAAC is in a unique position to conduct this work, as it uniquely 
qualified for this funding opportunity because of their political 
mandate, clearly acknowledged leadership by all partners, and 
significant experience to continue a strong and vital coordinating role 
for HIV programs.
    Summary of the award:
    Recipient: Namibia Ministry of Health and Social Services (MOHSS), 
Rwanda Biomedical Center, South African Medical Research Council, South 
African National AIDS Council Trust (SANAC), Tanzania Commission for 
AIDS (TACAIDS), President's Office--Regional Administration and Local 
Government (PO-RALG), and Vietnam Administration for HIV/AIDS Control 
(VAAC).
    Purpose of the Award: The purpose of these awards is to strengthen 
comprehensive and integrated service delivery for prevention and 
implement strategies and activities that strengthen local entities, 
support the coordination, management, and monitoring of multi-sectoral 
implementation, foster the government's capacity to provide 
comprehensive management of the HIV program, and implement a 
sustainable and quality-assured HIV diagnostic, testing, and health 
information management program in Namibia, Rwanda, South Africa, 
Tanzania, and Vietnam.
    Amount of Award: For MOHSS, the approximate year 1 funding amount 
will be $8,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Amount of Award: For Rwanda Biomedical Center, the approximate year 
1 funding amount will be $4,000,000 in Federal Fiscal Year (FYY) 2024 
funds, subject to the availability of funds. Funding amounts for years 
2-5 will be set at continuation.
    Amount of Award: For South African Medical Research Council, the 
approximate year 1 funding amount will be $(3,000,000 in Federal Fiscal 
Year (FYY) 2024 funds, subject to the availability of funds. Funding 
amounts for years 2-5 will be set at continuation.
    Amount of Award: For SANAC, the approximate year 1 funding amount 
will be $3,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Amount of Award: For TACAIDS, the approximate year 1 funding amount 
will be $500,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Amount of Award: For PO-RALG, the approximate year 1 funding amount 
will be $500,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds.
    Amount of Award: For VAAC, the approximate year 1 funding amount 
will be $6,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to 
the availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: These programs are authorized under Public Law 108-25 
(the United States Leadership Against HIV AIDS, Tuberculosis and 
Malaria Act of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110-293 
(the Tom Lantos and Henry J. Hyde United States Global Leadership 
Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 
2008), and Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 
2013).
    Period of Performance: The period for these awards will be 
September 30, 2024, through September 29, 2029.

    Dated: January 24, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Acting Chief Grants 
Management Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02505 Filed 2-6-24; 8:45 am]
BILLING CODE 4163-18-P